Misplaced Pages

AABB

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

AABB ( Association for the Advancement of Blood & Biotherapies ) is an international, not-for-profit organization representing individuals and institutions involved in the field of transfusion medicine and biotherapies.

#207792

77-558: The association works collaboratively to advance the field through the development and delivery of standards, accreditation and education programs. AABB is dedicated to its mission of improving lives by making transfusion medicine and biotherapies safe, available and effective worldwide. The association was founded in the United States in 1947 as the American Association of Blood Banks. In 2021, it changed its name to Association for

154-412: A Plymouth Rock hen which had developed a "large irregularly globular mass" on its left breast two months earlier. He identified the tumor as a "spindle-celled sarcoma." After several experiments of attempting to see the effect of the tumor exudate on healthy chicken, he realized that he could induce the same tumour in healthy chickens of the same breed only, so that genetic relatedness was important for

231-470: A catalyst for the rapid development of blood banks and transfusion techniques. Inspired by the need to give blood to wounded soldiers in the absence of a donor, Francis Peyton Rous at the Rockefeller University (then The Rockefeller Institute for Medical Research) wanted to solve the problems of blood transfusion. With a colleague, Joseph R. Turner, he made two critical discoveries: blood typing

308-453: A collection system capable of safe and easy preparation of multiple blood components from a single unit of whole blood. Further extending the shelf life of stored blood up to 42 days was an anticoagulant preservative, CPDA-1, introduced in 1979, which increased the blood supply and facilitated resource-sharing among blood banks. In the U.S., certain standards are set for the collection and processing of each blood product. "Whole blood" (WB)

385-498: A freezer at very low temperatures. The exact temperature depends on the glycerol concentration. Francis Peyton Rous Francis Peyton Rous ForMemRS ( / r aʊ s / ; October 5, 1879 – February 16, 1970) was an American pathologist at the Rockefeller University known for his works in oncoviruses , blood transfusion and physiology of digestion . A medical graduate from the Johns Hopkins University , he

462-547: A hospital laboratory that preserved, refrigerated and stored donor blood, Fantus originated the term "blood bank". Within a few years, hospital and community blood banks were established across the United States. Frederic Durán-Jordà fled to Britain in 1938, and worked with Janet Vaughan at the Royal Postgraduate Medical School at Hammersmith Hospital to create a system of national blood banks in London. With

539-407: A medical advice was clear: [If] clumping is present in the 9:1 mixture and to a less degree or not at all in the 1:1 mixture, it is certain that the blood of the patient agglutinates that of the donor and may perhaps hemolyze it. Transfusion in such cases is dangerous. Clumping in the 1:1 mixture with little or none in the 9:1 indicates that the plasma of the prospective donor agglutinates the cells of

616-438: A method for testing blood compatibility to avoid complications in transfusion. Although an Austrian physician Karl Landsteiner had discovered blood types a decade earlier, the practical usage was not yet developed, as Rous described: "The fate of Landsteiner's effort to call attention to the practical bearing of the group differences in human bloods provides an exquisite instance of knowledge marking time on technique. Transfusion

693-473: A mixture of 3 parts of human blood, 2 parts of isotonic citrate solution (3.8 per cent sodium citrate in water), and 5 parts of isotonic dextrose solution (5.4 per cent dextrose in water), the cells remain intact for about 4 weeks." A separate report indicates the use of citrate-saccharose (sucrose) could maintain blood cells for two weeks. They noticed that the preserved bloods were just like fresh bloods and that they "function excellently when reintroduced into

770-658: A modified Duran Erlenmeyer flask. The blood was stored in a sterile glass enclosed under pressure at 2 °C. During 30 months of work, the Transfusion Service of Barcelona registered almost 30,000 donors, and processed 9,000 liters of blood. In 1937 Bernard Fantus , director of therapeutics at the Cook County Hospital in Chicago , established one of the first hospital blood banks in the United States . In creating

847-480: A regulatory proxy. Opinions vary as to the best way to determine transfusion efficacy in a patient in vivo . In general, there are not yet any in vitro tests to assess quality deterioration or preservation for specific units of RBC blood product prior to their transfusion, though there is exploration of potentially relevant tests based on RBC membrane properties such as erythrocyte deformability and erythrocyte fragility (mechanical). Many physicians have adopted

SECTION 10

#1732858595208

924-658: A result of blood donation is stored and preserved for later use in blood transfusion . The term "blood bank" typically refers to a department of a hospital usually within a clinical pathology laboratory where the storage of blood product occurs and where pre-transfusion and blood compatibility testing is performed. However, it sometimes refers to a collection center, and some hospitals also perform collection. Blood banking includes tasks related to blood collection, processing, testing, separation, and storage. For blood donation agencies in various countries, see list of blood donation agencies and list of blood donation agencies in

1001-413: A so-called "restrictive protocol"—whereby transfusion is held to a minimum—due in part to the noted uncertainties surrounding storage lesion, in addition to the very high direct and indirect costs of transfusions, along with the increasing view that many transfusions are inappropriate or use too many RBC units. Platelet storage lesion is a very different phenomenon from RBC storage lesion, due largely to

1078-453: A special interest because of its extreme malignancy and a tendency to wide-spread metastasis... small quantities of a cell-free filtrate have sufficed to transmit the growth to susceptible fowls. This finding, that cancer could be transmitted by a virus (now known as the Rous sarcoma virus , a retrovirus ), was widely discredited by most of the field's experts at that time as "utter nonsense" as it

1155-429: A strategic blend of FIFO with last in, first out (LIFO). "Long-term" storage for all blood products is relatively uncommon, compared to routine/short-term storage. Cryopreservation of red blood cells is done to store rare units for up to ten years. The cells are incubated in a glycerol solution which acts as a cryoprotectant ("antifreeze") within the cells. The units are then placed in special sterile containers in

1232-518: A technique for preserving blood sample by using an acid, citrate . This enabled the first practical storage of blood samples for transfusion and was introduced by Oswald H. Robertson at the front line in Belgium in 1917 as the world's first blood bank. Rous was born in Baltimore, Maryland, to Charles Rous and Frances Anderson née Wood. He had two younger sisters. His father, a grain broker, died when he

1309-534: A training course on morbid anatomy at Friedrichstadt Municipal Hospital (Krankenhaus Dresden-Friedrichstadt) in Dresden under Christian Georg Schmorl . On his way home from Germany, he showed symptoms of pulmonary tuberculosis and was sent to the Adirondack Mountains in northeastern Upstate New York for recovery. After his return in 1908, Warthin informed him of a Rockefeller Scholarship for cancer research at

1386-406: A universal manner that does not account for differences among units of product; for example, testing for the post-transfusion RBC survival in vivo is done on a sample of healthy volunteers, and then compliance is presumed for all RBC units based on universal (GMP) processing standards. RBC survival does not guarantee efficacy, but it is a necessary prerequisite for cell function, and hence serves as

1463-580: A variety of other materials for the blood and biotherapies field, including the standards by which it accredits institutions. Since 1953, the organization has also operated a National Blood Exchange to facilitate transfers of blood products during shortages or when rare blood types are required. On June 1, 2018, Debra BenAvram, FASAE, CAE, became the association's chief executive officer (CEO). The AABB conducts assessments every two years of institutional member facilities that procure, process, store and/or distribute cellular therapy products to ensure they meet

1540-421: Is an expensive and time-consuming process, and is rarely done. Frozen red cells are given an expiration date of up to ten years and are stored at −85 °F (−65 °C). The less-dense blood plasma is made into a variety of frozen components, and is labeled differently based on when it was frozen and what the intended use of the product is. If the plasma is frozen promptly and is intended for transfusion, it

1617-476: Is five days old or less, to "ensure" optimal cell function. Also, some hospital blood banks will attempt to accommodate physicians' requests to provide low-aged RBC product for certain kinds of patients (e.g. cardiac surgery). More recently, novel approaches are being explored to complement or replace FIFO. One is to balance the desire to reduce average product age (at transfusion) with the need to maintain sufficient availability of non-outdated product, leading to

SECTION 20

#1732858595208

1694-405: Is in turn due largely to a higher storage temperature. Insufficient transfusion efficacy can result from red blood cell (RBC) blood product units damaged by so-called storage lesion —a set of biochemical and biomechanical changes which occur during storage. With red cells, this can decrease viability and ability for tissue oxygenation. Although some of the biochemical changes are reversible after

1771-755: Is indeed less effective but with others showing no such difference; nevertheless, as storage time remains the only available way to estimate quality status or loss, a first-in-first-out inventory management approach is standard presently. It is also important to consider that there is large variability in storage results for different donors, which combined with limited available quality testing, poses challenges to clinicians and regulators seeking reliable indicators of quality for blood products and storage systems. Transfusions of platelets are comparatively far less numerous, but they present unique storage/management issues. Platelets may only be stored for 7 days, due largely to their greater potential for contamination, which

1848-486: Is plasma via plasmapheresis , but red blood cells and platelets can be collected by similar methods. These products generally have the same shelf life and storage conditions as their conventionally-produced counterparts. Donors are sometimes paid; in the U.S. and Europe, most blood for transfusion is collected from volunteers while plasma for other purposes may be from paid donors. Most collection facilities as well as hospital blood banks also perform testing to determine

1925-575: Is referred to as the buffy coat and is sometimes removed to make platelets for transfusion. Platelets are typically pooled before transfusion and have a shelf life of 5 to 7 days, or 3 days once the facility that collected them has completed their tests. Platelets are stored at room temperature (72 °F or 22 °C) and must be rocked/agitated. Since they are stored at room temperature in nutritive solutions, they are at relatively high risk for growing bacteria . Some blood banks also collect products by apheresis . The most common component collected

2002-666: Is the proper name for one defined product, specifically unseparated venous blood with an approved preservative added. Most blood for transfusion is collected as whole blood. Autologous donations are sometimes transfused without further modification, however whole blood is typically separated (via centrifugation) into its components, with red blood cells (RBC) in solution being the most commonly used product. Units of WB and RBC are both kept refrigerated at 33.8 to 42.8 °F (1.0 to 6.0 °C), with maximum permitted storage periods ( shelf lives ) of 35 and 42 days respectively. RBC units can also be frozen when buffered with glycerol, but this

2079-405: Is typically labeled as fresh frozen plasma . If it is intended to be made into other products, it is typically labeled as recovered plasma or plasma for fractionation . Cryoprecipitate can be made from other plasma components. These components must be stored at 0 °F (−18 °C) or colder, but are typically stored at −22 °F (−30 °C). The layer between the red cells and the plasma

2156-505: The Clinical Laboratory Improvement Amendments (CLIA) for blood bank, transfusion service, and immunohematology reference laboratory operations. AABB hosts an annual meeting every fall for the dissemination of research and information for the blood and biotherapies field. The association publishes a monthly magazine, a weekly newsletter, and a peer-reviewed research journal titled Transfusion . AABB publishes

2233-1037: The Norwegian Academy of Science and Letters . He was appointed honorary fellow of the Weizmann Institute of Science and foreign correspondent of the Académie Nationale de Médecine in Paris. He also received the Kovalenko Medal of the National Academy of Sciences , the Distinguished Service Award of the American Cancer Society , the United Nations Prize for Cancer Research, and the Paul Ehrlich and Ludwig Darmstaedter Prize from

2310-690: The Soviet Union pioneered the transfusion of cadaveric blood from recently deceased donors. Yudin performed such a transfusion successfully for the first time on March 23, 1930, and reported his first seven clinical transfusions with cadaveric blood at the Fourth Congress of Ukrainian Surgeons at Kharkiv in September. Also in 1930, Yudin organized the world's first blood bank at the Nikolay Sklifosovsky Institute, which set an example for

2387-722: The University of Michigan as an instructor of pathology. Alfred Warthin, head of the pathology department, advised him to study German to pursue specialised pathological course in Germany. To earn extra salary, Warthin arranged for him temporary teaching position at the summer school. He published his first technical paper on white blood cell analysis in the Proceedings of the Society for Experimental Biology and Medicine (now Experimental Biology and Medicine ) in 1906. In 1907, he went to Germany for

AABB - Misplaced Pages Continue

2464-435: The blood type of patients and to identify compatible blood products, along with a battery of tests (e.g. disease) and treatments (e.g. leukocyte filtration) to ensure or enhance quality. The increasingly recognized problem of inadequate efficacy of transfusion is also raising the profile of RBC viability and quality. Notably, U.S. hospitals spend more on dealing with the consequences of transfusion-related complications than on

2541-678: The osmotic pressure in the blood vessels , preventing their collapse. The use of blood plasma as a substitute for whole blood and for transfusion purposes was proposed as early as 1918, in the correspondence columns of the British Medical Journal , by Gordon R. Ward. At the onset of World War II , liquid plasma was used in Britain. A large project, known as 'Blood for Britain' began in August 1940 to collect blood in New York City hospitals for

2618-470: The Advancement of Blood & Biotherapies to better reflect its mission and work. Virtually all blood banks in the United States are accredited by AABB. In addition, AABB accredits hospital transfusion services, biotherapies facilities, cord blood banks, relationship testing facilities, and various other facilities whose work relates to blood and biotherapies. Accreditation by AABB meets the requirements of

2695-575: The Federal Republic of Germany. Rous shared the Nobel Prize in Physiology or Medicine in 1966 with Charles Brenton Huggins "for his discovery of tumour-inducing viruses." As early as 1926, Karl Landsteiner had nominated him and subsequently received other 16 nominations up to 1951, but was selected 55 years after his initial discovery at the age of 87, and he is recorded as the oldest recipient of

2772-603: The Front. He also experimented with preserving separated red blood cells in iced bottles. Geoffrey Keynes , a British surgeon, developed a portable machine that could store blood to enable transfusions to be carried out more easily. The world's first blood donor service was established in 1921 by the secretary of the British Red Cross , Percy Lane Oliver . Volunteers were subjected to a series of physical tests to establish their blood group . The London Blood Transfusion Service

2849-640: The Nobel Prize in Medicine or Physiology. His remains "the longest 'incubation period' in the 110 years history of the Nobel Prizes in Physiology or Medicine." Rous married Marion Eckford de Kay in 1915 who survived him by fifteen years and died in 1985. He had three daughters, Marion (Marni), Ellen and Phoebe. Marni (1917–2015) was a children's book editor, and the wife of another Nobel Prize winner, Alan Lloyd Hodgkin . Phoebe married Thomas J. Wilson, director of

2926-578: The Rockefeller Institute for Medical Research (now Rockefeller University ) in New York. Using the grants, he studied lymphocytes on which he published a series of papers in 1908. Simon Flexner , director of the Rockefeller Institute and editor of the Experimental Biology and Medicine which published his papers, recognized his research interest and offered him to lead cancer research at

3003-571: The Rockefeller between 1915 and 1917, and learned the blood matching and preservation methods. He was attached to the RAMC in 1917, where he was instrumental in establishing the first blood banks, with soldiers as donors, in preparation for the anticipated Third Battle of Ypres . He used sodium citrate as the anticoagulant, and the blood was extracted from punctures in the vein, and was stored in bottles at British and American Casualty Clearing Stations along

3080-586: The Transfusion Service at the Barcelona Hospital at the start of the conflict, but the hospital was soon overwhelmed by the demand for blood and the paucity of available donors. With support from the Department of Health of the Spanish Republican Army , Duran established a blood bank for the use of wounded soldiers and civilians. The 300–400 ml of extracted blood was mixed with 10% citrate solution in

3157-428: The United States . Several types of blood transfusion exist: While the first blood transfusions were made directly from donor to receiver before coagulation , it was discovered that by adding anticoagulant and refrigerating the blood it was possible to store it for some days, thus opening the way for the development of blood banks. John Braxton Hicks was the first to experiment with chemical methods to prevent

AABB - Misplaced Pages Continue

3234-520: The association’s voluntary standards, including hematopoietic progenitor cell, umbilical cord blood stem cell, somatic cell product and clinical services facilities in the U.S. and worldwide that have earned AABB accreditation. Below are a list of Cell Therapy Cord Blood Facilities Accredited by the AABB in the United States: Blood banks A blood bank is a center where blood gathered as

3311-522: The blood is transfused, the biomechanical changes are less so, and rejuvenation products are not yet able to adequately reverse this phenomenon. Current regulatory measures are in place to minimize RBC storage lesion—including a maximum shelf life (currently 42 days), a maximum auto-hemolysis threshold (currently 1% in the US), and a minimum level of post-transfusion RBC survival in vivo (currently 75% after 24 hours). However, all of these criteria are applied in

3388-442: The blood samples of the donor and recipient were tested before. They developed a rapid and simple method for testing blood compatibility in which coagulation and the suitability of the blood for transfusion could be easily determined. They used sodium citrate to dilute the blood samples, and after mixing the recipient's and donor's blood in 9:1 and 1:1 parts, blood would either clump or remain watery after 15 minutes. Their result with

3465-541: The body." The use of sodium citrate with sugar, sometimes known as Rous-Turner solution, was the main discovery that paved the way for the development of various blood preservation methods and blood bank. Canadian Lieutenant Lawrence Bruce Robertson was instrumental in persuading the Royal Army Medical Corps (RAMC) to adopt the use of blood transfusion at the Casualty Clearing Stations for

3542-594: The coagulation of blood at St Mary's Hospital, London , in the late 19th century. His attempts, using phosphate of soda , however, were unsuccessful. The first non-direct transfusion was performed on March 27, 1914, by the Belgian doctor Albert Hustin , though this was a diluted solution of blood. The Argentine doctor Luis Agote used a much less diluted solution in November of the same year. Both used sodium citrate as an anticoagulant. The First World War acted as

3619-606: The combined costs of buying, testing/treating, and transfusing their blood. Routine blood storage is 42 days or 6 weeks for stored packed red blood cells (also called "StRBC" or "pRBC"), by far the most commonly transfused blood product, and involves refrigeration but usually not freezing. There has been increasing controversy about whether a given product unit's age is a factor in transfusion efficacy, specifically on whether "older" blood directly or indirectly increases risks of complications. Studies have not been consistent on answering this question, with some showing that older blood

3696-424: The conditions leading to liver damage and the effect on bile secretion. He and Philip D. McMaster worked out the main function of gall bladder as the site of bile concentration. He showed that bile was concentrated by the gallbladder from water as it is released from the liver, and this also helped to the understanding of diseases associated with bile secretions, such as jaundice and gallstone formation. Rous

3773-576: The course of the war. This system evolved into the National Blood Transfusion Service established in 1946, the first national service to be implemented. A blood collection program was initiated in the US in 1940 and Edwin Cohn pioneered the process of blood fractionation . He worked out the techniques for isolating the serum albumin fraction of blood plasma , which is essential for maintaining

3850-557: The details Shope papilloma virus. From his initial study, he knew that such tumor can "undergo progressive changes in the direction of malignancy when they grow vigorously." His research during the next three decades helped to confirm that viral papilloma can lead to cancers. The virus nature of the Rous sarcoma was shown by William Ewart Gye of the National Institute for Medical Research at Hampstead in 1925. The carcinogenic property

3927-473: The different functions of the products and purposes of the respective transfusions, along with different processing issues and inventory management considerations. Although as noted the primary inventory-management approach is first in, first out (FIFO) to minimize product expiration, there are some deviations from this policy—both in current practice as well as under research. For example, exchange transfusion of RBC in neonates calls for use of blood product that

SECTION 50

#1732858595208

4004-546: The establishment of further blood banks in different regions of the Soviet Union and in other countries. By the mid-1930s the Soviet Union had set up a system of at least 65 large blood centers and more than 500 subsidiary ones, all storing "canned" blood and shipping it to all corners of the country. One of the earliest blood banks was established by Frederic Durán-Jordà during the Spanish Civil War in 1936. Duran joined

4081-485: The export of plasma to Britain . A dried plasma package was developed, which reduced breakage and made the transportation, packaging, and storage much simpler. The resulting dried plasma package came in two tin cans containing 400 cc bottles. One bottle contained enough distilled water to reconstitute the dried plasma contained within the other bottle. In about three minutes, the plasma would be ready to use and could stay fresh for around four hours. Charles R. Drew

4158-528: The help of a few like minded individuals (including the eminent physician Edward William Archibald )—was able to persuade the British authorities of the merits of blood transfusion. Robertson went on to establish the first blood transfusion apparatus at a Casualty Clearing Station on the Western Front in the spring of 1917. Oswald Hope Robertson , a medical researcher and U.S. Army officer, worked with Rous at

4235-399: The institute. In 1909, he joined the laboratories as a full-time researcher at Rockefeller. In 1920, he was appointed Member of the Rockefeller Institute, and became Member Emeritus in 1945, the position he occupied till his death. Rous started his Rockefeller research on the tumors in rodents, and turned to that of chicken (specifically, a sarcoma ) in the early 1910. A woman brought him

4312-411: The introduction by J.F. Loutit and Patrick L. Mollison of acid-citrate-dextrose (ACD) solution, which reduced the volume of anticoagulant, permitted transfusions of greater volumes of blood and allowed longer-term storage. Carl Walter and W.P. Murphy Jr. introduced the plastic bag for blood collection in 1950. Replacing breakable glass bottles with durable plastic bags allowed for the evolution of

4389-604: The only difference being that it could be produced by a cell-free filtrate of a tumor. Experiments he continued with James B. Murphy and published made conclusive evidences for the cancerous nature of the infection. An experiment they did with W.H. Tytler in 1912 gave the first clue of virus as the filterable agent, but failed to make an exact identification. Rous continued to work on cancer up to 1915, after which he gave up due to failure to obtain other carcinogenic agents from chicken and mice, and general acceptance of his discovery. After 18 years, he returned to cancer research upon

4466-778: The outbreak of war looking imminent in 1938, the War Office created the Army Blood Supply Depot (ABSD) in Bristol headed by Lionel Whitby and in control of four large blood depots around the country. British policy through the war was to supply military personnel with blood from centralized depots, in contrast to the approach taken by the Americans and Germans where troops at the front were bled to provide required blood. The British method proved to be more successful at adequately meeting all requirements and over 700,000 donors were bled over

4543-513: The practical bearing of the group differences in human bloods provides an exquisite instance of knowledge marking time on technique. Transfusion was still not done because (until at least 1915), the risk of clotting was too great." In February 1916, they reported in the Journal of Experimental Medicine the key method for blood preservation. They replaced the additive, gelatine, with a mixture sodium citrate and glucose ( dextrose ) solution and found: "in

4620-484: The prospective recipient. The risk from transfusing is much less under such circumstances, but it may be doubted whether the blood is as useful as one which does not and is not agglutinated. A blood of the latter kind should always be chosen if possible. Rous was well aware that Austrian physician Karl Landsteiner had discovered blood types a decade earlier, but the practical usage was not yet developed, as he described: "The fate of Landsteiner's effort to call attention to

4697-422: The request of a colleague Richard Shope. In 1933, Shope had discovered that a skin tumor ( papilloma ) in cottontail rabbits was due to a filterable virus, later known as Shope papilloma virus , and showed in 1935 that the virus was transmissible in healthy rabbits. Shope realized the similarity as a cancer agent with Rous's virus and requested Rous for further investigation. Rous obliged and soon reported on

SECTION 60

#1732858595208

4774-404: The role of viruses in the development of certain types of cancer . He was awarded a Nobel Prize in Physiology or Medicine for his work in 1966, 55 years after his initial discovery and he remains the oldest recipient of the Nobel Prize in Medicine or Physiology. He and Joseph R. Turner studied methods to make use of blood types for blood transfusion . During World War I , they developed

4851-448: The specific tumor. His first report in May 1910 on spontaneous chicken tumor established the first avian tumor that was transplantable to other individuals. Speculating the medical importance, he noted that "there is no reason to suspect on these points [of growth and transmission] that the neoplasm will differ from the better-known tumors of mammals." He continued to maintain and transplant

4928-495: The time, blood transfusion was by direct person-to-person so that the preservation method allowed transfusion in the absence of a donor. An English physician Oswald H. Robertson , serving in the US Army, brought the new technique to Belgium in 1917. It became the world's first blood bank. Rous also made important contributions in the physiology of digestion focussing on the liver and gall bladder. With Louise D. Larimore, he described

5005-408: The tumor in different individuals. In 1911, he made a seminal observation that cell-free filtrate (using Berkefeld filter that separate bacteria and large microbes) of chicken sarcoma could produce a malignant tumor when transferred to other chickens, describing: A transmissible sarcoma of the chicken has been under observation in this laboratory for the past fourteen months, and it has assumed of late

5082-402: The voice of a young American who claimed to have transmitted by a cell-free filtrate a neoplasm—a chicken sarcoma. Of course this could not be true, and for years they did not even try to repeat his experiments. He was even accused of using faulty technique and contaminating the tumor samples with cancer cells. However, he was convinced that the malignancy was as those of any other cancer cells,

5159-485: The wounded. In October 1915, Robertson performed his first wartime transfusion with a syringe to a patient who had multiple shrapnel wounds. He followed this up with four subsequent transfusions in the following months, and his success was reported to Sir Walter Morley Fletcher , director of the Medical Research Committee . Robertson published his findings in the British Medical Journal in 1916, and—with

5236-551: Was 11 years of age. He studied at the local public schools up to secondary education. He received a scholarship to Johns Hopkins University from where he obtained a B.A. degree in 1900. He immediately took up medicine at the Johns Hopkins School of Medicine . While in the second year at the medical school, Rous contracted tuberculosis through his injured finger while performing an autopsy. A tuberculous bone ( axillary tuberculous lymphadenitis ) developed in his armpit and

5313-532: Was a medically accepted fact that cancer was not an infection. As recorded by Charles Oberling: Tumor pathology was then completely under the spell of the German school of pathologic anatomy which, probably as an aftermath of the antagonism between Robert Koch and [Rudolf] Virchow , was utterly opposed to any theory of an infectious origin of cancer. And suddenly, in opposition to all these dignified and bearded Herren Professoren who firmly believed what they said, rose

5390-453: Was appointed medical supervisor, and he was able to transform the test tube methods into the first successful mass production technique. Another important breakthrough came in 1939–40 when Karl Landsteiner , Alex Wiener, Philip Levine, and R.E. Stetson discovered the Rh blood group system , which was found to be the cause of the majority of transfusion reactions up to that time. Three years later,

5467-493: Was discouraged from becoming a practicing physician due to severe tuberculosis. After three years of working as an instructor of pathology at the University of Michigan , he became dedicated researcher at the Rockefeller Institute for Medical Research for the rest of his career. His discovery in 1911 that a chicken tumor was caused by a virus (later named Rous sarcoma virus ) led to more discoveries and understanding of

5544-886: Was elected a member of the United States National Academy of Sciences in 1927 and a member of the American Philosophical Society in 1939. He was elected a Foreign Member of the Royal Society (ForMemRS) in 1940 . He received the Albert Lasker Award for Basic Medical Research in 1958 and the National Medal of Science in 1965. He was also member of the Royal Society of Medicine , the Royal Danish Academy of Sciences and Letters , and

5621-584: Was free of charge and expanded rapidly. By 1925, it was providing services for almost 500 patients and it was incorporated into the structure of the British Red Cross in 1926. Similar systems were established in other cities including Sheffield , Manchester and Norwich , and the service's work began to attract international attention. Similar services were established in France, Germany, Austria, Belgium, Australia and Japan. Vladimir Shamov and Sergei Yudin in

5698-568: Was necessary to avoid blood clumping (coagulation) and blood samples could be preserved using chemical treatment. Their report in March 1915 to identify possible blood preservative was of a failure. The experiments with gelatine, agar, blood serum extracts, starch and beef albumin proved useless. In June 1915, they made the first important report in the Journal of the American Medical Association that agglutination could be avoided if

5775-434: Was still not done because (until at least 1915), the risk of clotting was too great." He and Turner also successfully developed a technique for prolonged blood preservation initially by adding gelatine in the blood sample. In 1916, they replaced the additive with a citrate-glucose solution which extended blood storage from one week to two weeks. The use of citrate was the key to the beginning of modern blood transfusion. At

5852-499: Was surgically removed. He was given leave from the medical school for recovery. His uncle got him a job as a cowboy at a cattle ranch in Texas, where he worked for a year. He was able to resume his medical course in 1904. Due to the disease, he considered himself as unfit to be a physician, or a "real doctor," for which he focused his interest in medical research. He obtained an M.D. degree in 1905. After completing an internship, Rous joined

5929-412: Was widely accepted after the discovery of the oncogene in 1960, the exact gene of which was identified in the 1970s as src . The outbreak of World War I inspired Rous to turn his attention to blood transfusion, as he learned soldiers were dying at the war fronts due to blood loss. In 1915, he collaborated with Joseph R. Turner to work on the methods of blood transfusion. That year, they devised

#207792